Chimeric Therapeutics
Biotechnology ResearchVictoria, Australia11-50 Employees
Chimeric Therapeutics is the ASX leader in cell therapy. As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercialising novel cell therapies with the most curative potential for patients. We believe cellular therapies have the promise to cure cancer not just delay disease progression. Follow our progress - ASX: CHM